drugset / Trial / NCT03254589

Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis

NCT03254589

RandomizedParallel-groupSingle-blindTreatment

Summary

The investigators will study the effects of methotrexate on blood pressure, arterial stiffness and endothelial function in patients with rheumatoid arthritis.

Timeline

Start
2017-10-01
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule Subcutaneous
Comparator Sulfasalazine Small molecule

Indications